S&P affirms Apria

Standard & Poor's said it affirmed its ratings, including the BB+ corporate credit rating, on Apria Healthcare Group Inc. after the company announced the $350 million acquisition of specialty infusion services provider Coram Inc.

The outlook is stable.

According to S&P, the ratings continue to reflect the exposure of the company's businesses to variable third-party reimbursement policies and pricing, the financial impact that fee cuts have had on the company in the past couple of years and risks related to the integration of Coram's operations.

These concerns are partially mitigated by the company's leading position in providing specialized home health care services and equipment and its history of generating significant cash flows, the agency noted.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.